The impact of COVID-19 monoclonal antibodies on clinical outcomes: A retrospective cohort study

• Published in: American journal of health-system pharmacy Vol. 79; no. 24; pp. 2222 - 2229
• Main Authors: R. Nagler, Arielle, Horwitz, Leora I, Jones, Simon, Petrilli, Christopher M, Iturrate, Eduardo, Lighter, Jennifer L, Phillips, Michael, Bosworth, Brian P, Polsky, Bruce, Volpicelli, Frank M, Dapkins, Isaac, Viswanathan, Anand, François, Fritz, Kalkut, Gary
• Format: Journal Article
• Language: English
• Published: 05.12.2022

Abstract Purpose Despite progress in the treatment of coronavirus disease 2019 (COVID-19), including the development of monoclonal antibodies (mAbs), more clinical data to support the use of mAbs in outpatients with COVID-19 is needed. This study is designed to determine the impact of bamlanivimab,...